Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma

Published:2008-04 Issue:4 Volume:7 Page:496-501
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Flaherty Keith T.,A. Rosen Mark,F. Heitjan Daniel,L. Gallagher Maryann,Schwartz Brian,D. Schnall Mitchell,O'Dwyer Peter J.

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.7.4.5624

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in imaging techniques of renal masses;World Journal of Radiology;2022-06-28

2. Advanced Magnetic Resonance Imaging (MRI) Techniques: Technical Principles and Applications in Nanomedicine;Cancers;2022-03-23

3. Assessing Tumour Haemodynamic Heterogeneity and Response to Choline Kinase Inhibition Using Clustered Dynamic Contrast Enhanced MRI Parameters in Rodent Models of Glioblastoma;Cancers;2022-02-26

4. Dynamic biomarker and imaging changes from a phase II study of pre‐ and post‐surgical sunitinib;BJU International;2021-11-02

5. An in silico validation framework for quantitative DCE-MRI techniques based on a dynamic digital phantom;Medical Image Analysis;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP